Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
02 Feb, 2022
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.